Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Shaman (SHMND) Discussion Group -- Ignore unavailable to you. Want to Upgrade?

To: bargainman who wrote (10)	7/6/1999 10:13:00 PM
From: JMarcus	Read Replies (1) \| Respond to of 22

For a transcript of Lisa Conte's personal account of what the FDA told Shaman in turning down Provir, see: ragingbull.com Marc

To: bargainman who wrote (10)	7/7/1999 3:44:00 PM
From: Jack Galt	Read Replies (1) \| Respond to of 22

In answer to your question of what LC knew and whens he knew it, I think the smoking gun is the ³resignation² in October of 1998, just about 8 weeks before the FDA rejected provir, of Dr. Athul Khwandwala (I am sure I have misspelled this) who was Sr. VP at SHMN for Regulatory Filings. Nobody resigns just before his long-worked on, soon-to-be successful baby gets borne, unlss something is amiss. My giess is that LC and mgt. knoew the bad news at least several months before it was made public. I always thought it was incredible how within days of saying provir was rejected, they put forth the new shmn ethnobotanicals venture and announced that they were exising the phamaceuticals business. Things like this take a LOT more planning and research than days!